Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

A year of various highlights for UFS
2016-12-19

Some other highlights:

Description: Prof Maryke Labuschagne, Bloemfontein Highlights Tags: Prof Maryke Labuschagne, Bloemfontein Highlights
The UFS was awarded five SARChI
(South African Research Chairs Initiative)
research chairs, the main goal of which is
to promote research excellence.
Read the full story


Description: Alumni Awards, Bloemfontein highlights Tags: Alumni Awards, Bloemfontein highlights

The UFS Chancellor’s Distinguished
Alumni Awards ceremony was held on
5 November 2016 on the
Bloemfontein Campus.
Read the full story


Description: Candice Thikeson, Bloemfontein Highlights Tags: Candice Thikeson, Bloemfontein Highlights

UFS student Candice Thikeson
completed a hat-trick of accolades when
she was named recipient of the Abe Bailey
Travel Bursary.

Read the full story

 

Description: Reitumetse Maloa, Bloemfontein Highlights Tags: Reitumetse Maloa, Bloemfontein Highlights

Reitumetse Maloa, a young researcher
at the UFS, is searching for a solution to
South Africa’s energy and electricity
problems from a rather unlikely
source: cow dung.

Read the full story


It was a year of various highlights for the University of the Free State (UFS) which has again illustrated the institution’s versatility by excelling on various fronts, from sports to research.

Some of these included Wayde van Niekerk winning a gold medal at the Olympic Games in Rio de Janeiro; research on the locomotion of the giraffe, and the awarding of honorary doctorates to people such as veteran journalist Max du Preez.

Van Niekerk breaks 400m world record

After his feat in Rio on 14 August 2016, Van Niekerk was described as “the next star” by former US sprinter Michael Johnson, whose 17-year-old 400m world record he broke in a time of 43,03. Johnson described the way in which the Kovsie outperformed the 400m field as “a massacre”.

Wayde van Niekerk was described as “the next star" by Michael Johnson, whose 17-year-old 400m world record he broke in a time of 43.03.


Max du Preez and Trevor Manuel honoured


Du Preez (Humanities) said he was excited about the young minds he had interacted with at the Winter Graduation ceremony of the UFS. The leading journalist and political analyst was one of four recipients of honorary doctorates from the university on June 30 2016. The others were Prof Joel Samoff (Humanities), former finance minister Trevor Manuel, and Dr Reuel Jethro Khoza (both Economic and Management Sciences.

Research of great value for conservation


Dr Francois Deacon, Department of Animal, Wildlife, and Grassland Sciences at the UFS, and Dr Chris Basu, a veterinarian at the Royal Veterinary College in the UK, conducted research on the manner in which giraffes locomote from one place to another.

Very little research has been done on the manner in which these animals move. The research will assist in understanding aspects such as the giraffe’s anatomy and function, as well as the energy it utilises in locomoting. Such information could help researchers understand where giraffes fit into the ecosystem and the data would be of great value for large-scale conservation efforts.

 

 

 

Read more on these highlights:

 

Wayde van Niekerk:

15 August 2016: Wayde the next big star, says Michael Johnson
20 September 2016: I don’t see myself as a star, says Wayde
27 October 2016: Wayde, Karla shine again at KovsieSport gala night
24 November 2016: Wayde keeps winning off the track

Honorary doctorates:

29 June 2016: UFS will award four honorary doctorates during Winter Graduation ceremonies
2 July 2016: Trevor Manuel and Max du Preez among the recipients of honorary doctorates at UFS graduation

Giraffe research:

9 March 2016: Giraffe research broadcast on National Geographic channel
23 August 2016: Research on locomotion of giraffes valuable for conservation of this species
18 November 2016: Studies to reveal correlation between terrain, energy use, and giraffe locomotion

 

 

 

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept